Biotricity Inc. announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux® and BiotresTM. The distribution agreement covers Bioflux and Biotres and will be distributed directly to hospitals and clinics for professional medical utilization with suitable patients.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -2.42% | +6.14% | +5.22% |
26/04 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
19/04 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
+5.22% | 1.43Cr | |
-17.75% | 281.78Cr | |
-15.42% | 8.07Cr | |
+10.14% | 5.07Cr |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. Signs Distribution Agreement with Top 5 Distributor for Its Cardiac Monitoring Solutions